|
|
|
|
|
|
by vibrio
1819 days ago
|
|
|
I think "grift" is a bit cynical. I agree the 'biobucks' concept largely exits, but it also good deal-making. A huge upfront is 100% risk on the buyer. Paying out incrementally for accomplishments is common and good business sense risk-sharing and should happen in almost any industry. The larger point is that Moderna was flush with cash for years before COVID, and the DARPA money wasn't that 'crazy' of an investment, or essential to Moderna's progress. |
|
|